ArticleDrug design, development and therapy2018

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.

Wendu Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.